Joshua Brodsky

Senior Director, Investor Relations & Corporate Communications at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Joshua Brodsky's Colleagues at Alnylam Pharmaceuticals
Timothy Mooney

Director, US Physician and Patient Marketing Lead, Lumasiran

Contact Timothy Mooney

Scott Peterson

Principal Associate Scientist

Contact Scott Peterson

Roumen Radinov

Director, Process Chemistry

Contact Roumen Radinov

Jayaprakash Nair

Senior Director, Chemistry, Delivery Science-Research

Contact Jayaprakash Nair

Yansong Cheng

Associate Director Biostatistics

Contact Yansong Cheng

Jeff Allen

Associate Director, Toxicology

Contact Jeff Allen

View All Joshua Brodsky's Colleagues
Joshua Brodsky's Contact Details
HQ
(617) 551-8200
Location
Somerville, Massachusetts, United States
Company
Alnylam Pharmaceuticals
Joshua Brodsky's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Joshua Brodsky
Joshua Brodsky currently works for Alnylam Pharmaceuticals.
Joshua Brodsky's role at Alnylam Pharmaceuticals is Senior Director, Investor Relations & Corporate Communications.
Joshua Brodsky's email address is ***@alnylam.com. To view Joshua Brodsky's full email address, please signup to ConnectPlex.
Joshua Brodsky works in the SaaS industry.
Joshua Brodsky's colleagues at Alnylam Pharmaceuticals are Timothy Mooney, Scott Peterson, Roumen Radinov, Jayaprakash Nair, David Mosher, Yansong Cheng, Jeff Allen and others.
Joshua Brodsky's phone number is (617) 551-8200
See more information about Joshua Brodsky